Aspergillosis Invasive: Clinical Trials

2 trials for Aspergillosis Invasive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Not yet recruiting 1

Follow Aspergillosis Invasive: new trials by email Literature Review of Aspergillosis Invasive trials Research Report on Aspergillosis Invasive

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm
Individualization of first voriconazole maintenance doses - Aspergillosis Invasive, Fungal Infection
Phase 4Not yet recruitingUniversity Hospital, Grenoble302024-10-012024-09-03
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels
Voriconazole genotype-specific dosing, Standard of Care - Aspergillosis Invasive, Fungal Infection
Phase 4CompletedUniversity Health Network, Toronto302018-01-102020-11-03

Narrower conditions

Mycoses (2)  ·  Hematologic Neoplasms (1)

Broader conditions

Bacterial Infections and Mycoses (2)  ·  Infections (2)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Standard of Care (1)

Sponsors

University Health Network, Toronto (1)  ·  University Hospital, Grenoble (1)

Countries

Canada (1)  ·  France (1)

Top investigators

Gautier-Veyret Elodie (1)  ·  Marisa Battistella, PharmD (1)